skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 41  for All Library Resources

Results 1 2 3 next page
Show only
Refined by: subject: Diabetes remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Six Months of Hybrid Closed-Loop Versus Manual Insulin Delivery With Fingerprick Blood Glucose Monitoring in Adults With Type 1 Diabetes: A Randomized, Controlled Trial
Material Type:
Article
Add to My Research

Six Months of Hybrid Closed-Loop Versus Manual Insulin Delivery With Fingerprick Blood Glucose Monitoring in Adults With Type 1 Diabetes: A Randomized, Controlled Trial

Diabetes care, 2020-12, Vol.43 (12), p.3024-3033 [Peer Reviewed Journal]

2020 by the American Diabetes Association. ;Copyright American Diabetes Association Dec 1, 2020 ;ISSN: 0149-5992 ;EISSN: 1935-5548 ;DOI: 10.2337/dc20-1447 ;PMID: 33055139

Full text available

2
Efficacy and Safety of Evolocumab in Chronic Kidney Disease in the FOURIER Trial
Material Type:
Article
Add to My Research

Efficacy and Safety of Evolocumab in Chronic Kidney Disease in the FOURIER Trial

Journal of the American College of Cardiology, 2019-06, Vol.73 (23), p.2961-2970 [Peer Reviewed Journal]

Copyright © 2019 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved. ;2019. American College of Cardiology Foundation ;ISSN: 0735-1097 ;ISSN: 1558-3597 ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2019.03.513 ;PMID: 31196453

Full text available

3
Effect of fenofibrate on amputation events in people with type 2 diabetes mellitus (FIELD study): a prespecified analysis of a randomised controlled trial
Material Type:
Article
Add to My Research

Effect of fenofibrate on amputation events in people with type 2 diabetes mellitus (FIELD study): a prespecified analysis of a randomised controlled trial

The Lancet (British edition), 2009-05, Vol.373 (9677), p.1780-1788 [Peer Reviewed Journal]

Elsevier Ltd ;2009 Elsevier Ltd ;2009 INIST-CNRS ;Copyright Elsevier Limited May 23-May 29, 2009 ;2009 Elsevier Ltd. All rights reserved. 2009 Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(09)60698-X ;PMID: 19465233 ;CODEN: LANCAO

Full text available

4
FKBPL is associated with metabolic parameters and is a novel determinant of cardiovascular disease
Material Type:
Article
Add to My Research

FKBPL is associated with metabolic parameters and is a novel determinant of cardiovascular disease

Scientific reports, 2020-12, Vol.10 (1), p.21655-21655, Article 21655 [Peer Reviewed Journal]

The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2020 ;ISSN: 2045-2322 ;EISSN: 2045-2322 ;DOI: 10.1038/s41598-020-78676-6 ;PMID: 33303872

Full text available

5
An Assessment of Clinical Continuous Glucose Monitoring Targets for Older and High-Risk People Living with Type 1 Diabetes
Material Type:
Article
Add to My Research

An Assessment of Clinical Continuous Glucose Monitoring Targets for Older and High-Risk People Living with Type 1 Diabetes

Diabetes technology & therapeutics, 2023-02, Vol.25 (2), p.18-115 [Peer Reviewed Journal]

2023, Mary Ann Liebert, Inc., publishers ;Copyright Mary Ann Liebert, Inc. Feb 2023 ;ISSN: 1520-9156 ;EISSN: 1557-8593 ;DOI: 10.1089/dia.2022.0350 ;PMID: 36315189

Full text available

6
Insulin micro-secretion in Type 1 diabetes and related microRNA profiles
Material Type:
Article
Add to My Research

Insulin micro-secretion in Type 1 diabetes and related microRNA profiles

Scientific reports, 2021-06, Vol.11 (1), p.11727-11727, Article 11727 [Peer Reviewed Journal]

The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2021 ;ISSN: 2045-2322 ;EISSN: 2045-2322 ;DOI: 10.1038/s41598-021-90856-6 ;PMID: 34083567

Full text available

7
HDL-C and HDL-C/ApoA-I Predict Long-Term Progression of Glycemia in Established Type 2 Diabetes
Material Type:
Article
Add to My Research

HDL-C and HDL-C/ApoA-I Predict Long-Term Progression of Glycemia in Established Type 2 Diabetes

Diabetes care, 2014-08, Vol.37 (8), p.2351-2358 [Peer Reviewed Journal]

2015 INIST-CNRS ;2014 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. ;Copyright American Diabetes Association Aug 2014 ;ISSN: 0149-5992 ;EISSN: 1935-5548 ;DOI: 10.2337/dc13-2738 ;PMID: 24804699 ;CODEN: DICAD2

Full text available

8
Relationship of low molecular weight fluorophore levels with clinical factors and fenofibrate effects in adults with type 2 diabetes
Material Type:
Article
Add to My Research

Relationship of low molecular weight fluorophore levels with clinical factors and fenofibrate effects in adults with type 2 diabetes

Scientific reports, 2021-09, Vol.11 (1), p.18708-18708, Article 18708 [Peer Reviewed Journal]

2021. The Author(s). ;The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2021 ;ISSN: 2045-2322 ;EISSN: 2045-2322 ;DOI: 10.1038/s41598-021-98064-y ;PMID: 34548531

Full text available

9
Effect of 6 months hybrid closed-loop insulin delivery in young people with type 1 diabetes: a randomised controlled trial protocol
Material Type:
Article
Add to My Research

Effect of 6 months hybrid closed-loop insulin delivery in young people with type 1 diabetes: a randomised controlled trial protocol

BMJ open, 2018-08, Vol.8 (8), p.e020275-e020275 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2018. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2018 Author(s) (or their employer(s)) 2018. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2018. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2018 ;ISSN: 2044-6055 ;EISSN: 2044-6055 ;DOI: 10.1136/bmjopen-2017-020275 ;PMID: 30104309

Full text available

10
Baseline Circulating FGF21 Concentrations and Increase after Fenofibrate Treatment Predict More Rapid Glycemic Progression in Type 2 Diabetes: Results from the FIELD Study
Material Type:
Article
Add to My Research

Baseline Circulating FGF21 Concentrations and Increase after Fenofibrate Treatment Predict More Rapid Glycemic Progression in Type 2 Diabetes: Results from the FIELD Study

Clinical chemistry (Baltimore, Md.), 2017-07, Vol.63 (7), p.1261-1270 [Peer Reviewed Journal]

2017 American Association for Clinical Chemistry. ;COPYRIGHT 2017 American Association for Clinical Chemistry, Inc. ;Copyright American Association for Clinical Chemistry Jul 2017 ;ISSN: 0009-9147 ;EISSN: 1530-8561 ;DOI: 10.1373/clinchem.2016.270876 ;PMID: 28606915

Full text available

11
Can Self-Rated Health Scores Be Used for Risk Prediction in Patients With Type 2 Diabetes?
Material Type:
Article
Add to My Research

Can Self-Rated Health Scores Be Used for Risk Prediction in Patients With Type 2 Diabetes?

Diabetes care, 2008-04, Vol.31 (4), p.795-797 [Peer Reviewed Journal]

2008 INIST-CNRS ;COPYRIGHT 2008 American Diabetes Association ;Copyright American Diabetes Association Apr 2008 ;ISSN: 0149-5992 ;EISSN: 1935-5548 ;DOI: 10.2337/dc07-1391 ;PMID: 18184900 ;CODEN: DICAD2

Full text available

12
Impact of metabolic syndrome and its components on cardiovascular disease event rates in 4900 patients with type 2 diabetes assigned to placebo in the FIELD randomised trial
Material Type:
Article
Add to My Research

Impact of metabolic syndrome and its components on cardiovascular disease event rates in 4900 patients with type 2 diabetes assigned to placebo in the FIELD randomised trial

Cardiovascular diabetology, 2011-11, Vol.10 (1), p.102-102 [Peer Reviewed Journal]

2011 Scott et al; licensee BioMed Central Ltd. ;2011 Scott et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. ;Copyright ©2011 Scott et al; licensee BioMed Central Ltd. 2011 Scott et al; licensee BioMed Central Ltd. ;ISSN: 1475-2840 ;EISSN: 1475-2840 ;DOI: 10.1186/1475-2840-10-102 ;PMID: 22104275

Full text available

13
Clinical efficacy and safety of achieving very low LDL-cholesterol concentrations with the PCSK9 inhibitor evolocumab: a prespecified secondary analysis of the FOURIER trial
Material Type:
Article
Add to My Research

Clinical efficacy and safety of achieving very low LDL-cholesterol concentrations with the PCSK9 inhibitor evolocumab: a prespecified secondary analysis of the FOURIER trial

The Lancet (British edition), 2017-10, Vol.390 (10106), p.1962-1971 [Peer Reviewed Journal]

2017 Elsevier Ltd ;Copyright © 2017 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Oct 28, 2017 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(17)32290-0 ;PMID: 28859947

Full text available

14
Cardiovascular Safety of Lorcaserin in Overweight or Obese Patients
Material Type:
Article
Add to My Research

Cardiovascular Safety of Lorcaserin in Overweight or Obese Patients

The New England journal of medicine, 2018-09, Vol.379 (12), p.1107-1117 [Peer Reviewed Journal]

Copyright © 2018 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1808721 ;PMID: 30145941

Full text available

15
Serum 25-hydroxyvitamin D: a predictor of macrovascular and microvascular complications in patients with type 2 diabetes
Material Type:
Article
Add to My Research

Serum 25-hydroxyvitamin D: a predictor of macrovascular and microvascular complications in patients with type 2 diabetes

Diabetes care, 2015-03, Vol.38 (3), p.521-528 [Peer Reviewed Journal]

2015 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. ;Copyright American Diabetes Association Mar 2015 ;ISSN: 0149-5992 ;EISSN: 1935-5548 ;DOI: 10.2337/dc14-0180 ;PMID: 25524951 ;CODEN: DICAD2

Full text available

16
An Update on the Molecular Actions of Fenofibrate and Its Clinical Effects on Diabetic Retinopathy and Other Microvascular End Points in Patients With Diabetes
Material Type:
Article
Add to My Research

An Update on the Molecular Actions of Fenofibrate and Its Clinical Effects on Diabetic Retinopathy and Other Microvascular End Points in Patients With Diabetes

Diabetes (New York, N.Y.), 2013-12, Vol.62 (12), p.3968-3975 [Peer Reviewed Journal]

2015 INIST-CNRS ;COPYRIGHT 2013 American Diabetes Association ;COPYRIGHT 2013 American Diabetes Association ;Copyright American Diabetes Association Dec 2013 ;2013 by the American Diabetes Association. 2013 ;ISSN: 0012-1797 ;EISSN: 1939-327X ;DOI: 10.2337/db13-0800 ;PMID: 24264394 ;CODEN: DIAEAZ

Full text available

17
Shortened Leukocyte Telomere Length Is Associated With Glycemic Progression in Type 2 Diabetes: A Prospective and Mendelian Randomization Analysis
Material Type:
Article
Add to My Research

Shortened Leukocyte Telomere Length Is Associated With Glycemic Progression in Type 2 Diabetes: A Prospective and Mendelian Randomization Analysis

Diabetes care, 2022-03, Vol.45 (3), p.701-709 [Peer Reviewed Journal]

2022 by the American Diabetes Association. ;Copyright American Diabetes Association Mar 2022 ;2022 by the American Diabetes Association 2022 ;ISSN: 0149-5992 ;EISSN: 1935-5548 ;DOI: 10.2337/dc21-1609 ;PMID: 35085380

Full text available

18
Predicting the Effect of Fenofibrate on Cardiovascular Risk for Individual Patients With Type 2 Diabetes
Material Type:
Article
Add to My Research

Predicting the Effect of Fenofibrate on Cardiovascular Risk for Individual Patients With Type 2 Diabetes

Diabetes care, 2018-06, Vol.41 (6), p.1244-1250 [Peer Reviewed Journal]

2018 by the American Diabetes Association. ;Copyright American Diabetes Association Jun 1, 2018 ;ISSN: 0149-5992 ;EISSN: 1935-5548 ;DOI: 10.2337/dc17-0968 ;PMID: 29472432

Full text available

19
Shortened Relative Leukocyte Telomere Length Is Associated With Prevalent and Incident Cardiovascular Complications in Type 2 Diabetes: Analysis From the Hong Kong Diabetes Register
Material Type:
Article
Add to My Research

Shortened Relative Leukocyte Telomere Length Is Associated With Prevalent and Incident Cardiovascular Complications in Type 2 Diabetes: Analysis From the Hong Kong Diabetes Register

Diabetes care, 2020-09, Vol.43 (9), p.2257-2265 [Peer Reviewed Journal]

2020 by the American Diabetes Association. ;Copyright American Diabetes Association Sep 1, 2020 ;ISSN: 0149-5992 ;EISSN: 1935-5548 ;DOI: 10.2337/dc20-0028 ;PMID: 32661111

Full text available

20
Shortening of telomere length by metabolic factors in diabetes: protective effects of fenofibrate
Material Type:
Article
Add to My Research

Shortening of telomere length by metabolic factors in diabetes: protective effects of fenofibrate

Journal of cell communication and signaling, 2019-12, Vol.13 (4), p.523-530 [Peer Reviewed Journal]

The International CCN Society 2019 ;2019© The International CCN Society 2019 ;ISSN: 1873-9601 ;EISSN: 1873-961X ;DOI: 10.1007/s12079-019-00521-x ;PMID: 31203557

Full text available

Results 1 - 20 of 41  for All Library Resources

Results 1 2 3 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (39)

Refine My Results

Creation Date 

From To
  1. Before 2011  (3)
  2. 2011 To 2013  (5)
  3. 2014 To 2016  (5)
  4. 2017 To 2020  (19)
  5. After 2020  (10)
  6. More options open sub menu

Resource Type 

  1. Articles  (40)
  2. Text Resources  (1)
  3. More options open sub menu

Searching Remote Databases, Please Wait